High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies

High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies

Objectives: Modern management of myeloma has significantly improved survival, with increasing numbers of patients living beyond a decade. However, little is known about the long-term cardiovascular and respiratory status of intensively treated and multiply relapsed survivors.

Bibliographic Details
Main Authors: Samuelson, Clare, O'Toole, Laurence, Boland, Elaine, Greenfield, Diana, Ezaydi, Yousef, Ahmedzai, Sam H., Snowden, John A.
Format: Online
Language:English
Published: Taylor & Francis 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950454/
id pubmed-4950454
recordtype oai_dc
spelling pubmed-49504542016-08-05 High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies Samuelson, Clare O'Toole, Laurence Boland, Elaine Greenfield, Diana Ezaydi, Yousef Ahmedzai, Sam H. Snowden, John A. Hematological Malignancy Objectives: Modern management of myeloma has significantly improved survival, with increasing numbers of patients living beyond a decade. However, little is known about the long-term cardiovascular and respiratory status of intensively treated and multiply relapsed survivors. Taylor & Francis 2016-05-27 2016-03-16 /pmc/articles/PMC4950454/ /pubmed/27077780 http://dx.doi.org/10.1080/10245332.2015.1122258 Text en © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Samuelson, Clare
O'Toole, Laurence
Boland, Elaine
Greenfield, Diana
Ezaydi, Yousef
Ahmedzai, Sam H.
Snowden, John A.
spellingShingle Samuelson, Clare
O'Toole, Laurence
Boland, Elaine
Greenfield, Diana
Ezaydi, Yousef
Ahmedzai, Sam H.
Snowden, John A.
High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies
author_facet Samuelson, Clare
O'Toole, Laurence
Boland, Elaine
Greenfield, Diana
Ezaydi, Yousef
Ahmedzai, Sam H.
Snowden, John A.
author_sort Samuelson, Clare
title High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies
title_short High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies
title_full High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies
title_fullStr High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies
title_full_unstemmed High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies
title_sort high prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: the case for ‘late effects’ screening and preventive strategies
description Objectives: Modern management of myeloma has significantly improved survival, with increasing numbers of patients living beyond a decade. However, little is known about the long-term cardiovascular and respiratory status of intensively treated and multiply relapsed survivors.
publisher Taylor & Francis
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950454/
_version_ 1613611626732191744

Similar Items